SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-19-072949
Filing Date
2019-12-16
Accepted
2019-12-16 14:00:00
Documents
1
Group Members
BPIFRANCE INVESTISSEMENT S.A.S.BPIFRANCE S.A.CAISSE DES DEPOTSEPIC BPIFRANCEFONDS INNOBIO FPCI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-26312_1sc13da.htm SC 13D/A 262005
  Complete submission text file 0001104659-19-072949.txt   263812
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87213 | Film No.: 191286632
SIC: 2834 Pharmaceutical Preparations

Mailing Address 27-31 AVENUE DU GENERAL LECLERC 94710 MAISONS ALFORT CEDEX FRANCE PARIS I0 75007
Business Address 27-31 AVENUE DU GENERAL LECLERC 94710 MAISONS ALFORT CEDEX FRANCE PARIS I0 75007 33153898789
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A